715 260 WATSON
Pill imprint 715 260 WATSON has been identified as Quinine sulfate 260 mg.
Quinine is used in the treatment of malaria; nocturnal leg cramps and belongs to the drug class antimalarial quinolines. Risk cannot be ruled out during pregnancy.
Quinine 260 mg is not subject to the Controlled Substances Act.
See also related documents.
Quinine sulfate Images
- Imprint:
-
715 260
WATSON - Strength:
- 260 mg
- Color:
- White
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Antimalarial quinolines
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Watson Pharmaceuticals
More Quinine Sulfate resources
- Quinine (Wolters Kluwer)
- Quinine Capsules (Wolters Kluwer)
- quinine (Cerner Multum)
- Quinamm (Micromedex) - Includes Dosage Information
- Quiphile (Micromedex) - Includes Dosage Information
- quinine (Micromedex) - Includes Dosage Information
- Quinine Sulfate (AHFS DI)
- Quinine Sulfate (Wolters Kluwer)
- Quinine (Wolters Kluwer)


